Sequential Therapies for Proliferative Lupus Nephritis
Top Cited Papers
Open Access
- 4 March 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (10) , 971-980
- https://doi.org/10.1056/nejmoa031855
Abstract
Long-term therapy with cyclophosphamide enhances renal survival in patients with proliferative lupus nephritis; however, the beneficial effect of cyclophosphamide must be weighed against its considerable toxic effects.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus NephritisNew England Journal of Medicine, 2000
- Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus NephritisAnnals of Internal Medicine, 1996
- Sequential Therapy for Diffuse Proliferative and Membranous Lupus Nephritis: Cyclophosphamide and Prednisolone Followed by Azathioprine and PrednisoloneNephron, 1995
- Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide TherapyAnnals of Internal Medicine, 1993
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- A Controlled Trial of Plasmapheresis Therapy in Severe Lupus NephritisNew England Journal of Medicine, 1992
- Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone onlyArthritis & Rheumatism, 1991
- Lymphocyte‐Selective Antiproliferative and Immunosuppressive Effects of Mycophenolic Acid in MiceScandinavian Journal of Immunology, 1991
- Long-term follow-up of patients with lupus nephritisThe American Journal of Medicine, 1987
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986